Education
About Us
Working with TipRanks
Follow Us
Electrocore (ECOR)
:ECOR
ECOR Stock Chart & Stats
Day’s Range― - ―
52-Week Range$5.02 - $19.49
Previous CloseN/A
Volume24.66K
Average Volume (3M)146.44K
Market Cap
$54.45M
Enterprise Value$99.73M
Total Cash (Recent Filing)-$416.34K
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta1.35
Next Earnings
May 01, 2025EPS Estimate
-0.48Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.70
Shares Outstanding7,193,092
10 Day Avg. Volume100,000
30 Day Avg. Volume146,443
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)2.29
Price to Cash Flow (P/CF)-11.50
P/FCF Ratio0.00
Enterprise Value/Market Cap1.83
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit4.66
Enterprise Value/Ebitda-8.92
Forecast
1Y Price Target
$25.33Price Target Upside234.61% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
---
Electrocore News
PremiumCompany Announcements
ElectroCore’s Earnings Call: Robust Growth Amid Challenges
PremiumCompany Announcements
ElectroCore Reports Strong 2024 Financial Growth
PremiumCompany Announcements
Electrocore Board Restructures After Director Resignation---
Bulls Say, Bears Say
Bulls Say
Acquisition ImpactThe acquisition of NeuroMetrix is expected to be accretive to both the top and bottom line for ECOR, increasing the company’s total addressable market and diversifying its portfolio of non-invasive wellness products.
Business Growth OpportunitiesA premium valuation for ECOR is justified due to substantial growth opportunities in both its prescription and over-the-counter business segments, as well as the potential to expand indications for its gammaCore device.
Financial PerformanceECOR's strong performance in 4Q24 marked its ninth consecutive quarter of record revenue, reflecting deeper penetration within the VA/DoD channel and broader adoption of its Truvaga line of OTC wellness devices.
Bears Say
Lack Of Forward GuidanceThe stock decline is mostly attributed to the company not issuing forward guidance, which it has done in the past.
Potential Supply Chain IssuesThere is potential for the VA/DoD channel to soften due to uncertainties related to possible reductions of supply chain staff in the VA system.
---
Options Prices
Currently, No data available
---
Ownership Overview
20.57% Insiders
3.15% Mutual Funds
0.03% Other Institutional Investors
73.17% Public Companies and
Individual Investors
ECOR FAQ
What was Electrocore’s price range in the past 12 months?
Electrocore lowest stock price was $5.02 and its highest was $19.49 in the past 12 months.
What is Electrocore’s market cap?
Electrocore’s market cap is $54.45M.
When is Electrocore’s upcoming earnings report date?
Electrocore’s upcoming earnings report date is May 01, 2025 which is in 3 days.
How were Electrocore’s earnings last quarter?
Electrocore released its earnings results on Mar 12, 2025. The company reported -$0.37 earnings per share for the quarter, missing the consensus estimate of -$0.3 by -$0.07.
Is Electrocore overvalued?
According to Wall Street analysts Electrocore’s price is currently Undervalued.
Does Electrocore pay dividends?
Electrocore does not currently pay dividends.
What is Electrocore’s EPS estimate?
Electrocore’s EPS estimate is -0.48.
How many shares outstanding does Electrocore have?
Electrocore has 7,193,092 shares outstanding.
What happened to Electrocore’s price movement after its last earnings report?
Electrocore reported an EPS of -$0.37 in its last earnings report, missing expectations of -$0.3. Following the earnings report the stock price went down -26.538%.
Which hedge fund is a major shareholder of Electrocore?
Currently, no hedge funds are holding shares in ECOR
---
Electrocore Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$25.33 (234.61% Upside)
$25.33 (234.61% Upside)
Blogger Sentiment
Bullish
ECOR Sentiment 70%
Sector Average 70%
Sector Average 70%
Insider Transactions
Bought Shares
Worth $57.1K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.1%
Last 30 Days ▼ 3.6%
Last 30 Days ▼ 3.6%
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
33.98%
12-Months-Change
Fundamentals
Return on Equity
-158.63%
Trailing 12-Months
Asset Growth
31.92%
Trailing 12-Months
Company Description
Electrocore
electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults. Its lead product is gammaCore Sapphire, a rechargeable and reloadable handheld device for regular or intermittent use over many years. The company was incorporated in 2005 and is headquartered in Rockaway, New Jersey.
---
ECOR Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted strong revenue growth, particularly in the VA channel and Truvaga sales, alongside improved financial metrics and strategic acquisitions. However, challenges were noted in the TAC-STIM product line, flat revenue in non-U.S. markets, and slower-than-expected progress in the Kaiser channel.Read More>---
ECOR Stock 12 Month Forecast
Average Price Target
$25.33
▲(234.61% Upside)
Technical Analysis
---